Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13-valent pneumococcal conjugate vaccine in healthy children
CTR20160658Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Sep 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, invasive pneumococcal disease (IPD), sponsored by Beijing Minhai Biological. Started Sep 2016; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal diseaseinvasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on CTR20160658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160658.